Researcher
Herlinde Dumez
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Publications
11 - 20 of 64
- A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours(2020)
Authors: Herlinde Dumez, Patrick Schöffski
Pages: 191 - 197 - TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castrationresistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin(2020)
Authors: Herlinde Dumez
Pages: S294 - S295 - Metastasectomy of oligometastatic urothelial cancer: a single-center experience(2020)
Authors: Tim Muilwijk, Murat Akand, Frank Van der Aa, Herlinde Dumez, Gert De Meerleer, Dirk Van Raemdonck, Paul De Leyn, Hendrik Van Poppel, Maarten Albersen, Steven Joniau
Pages: 1296 - 1305 - Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial(2020)
Authors: Charlien Berghen, Steven Joniau, Kato Rans, Gaëtan Devos, Herlinde Dumez, Maarten Albersen, Karolien Goffin, Karin Haustermans, Gert De Meerleer
- Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis(2020)
Authors: Patrick Schöffski, Daphne Hompes, Paul De Leyn, Willy Coosemans, Dirk Van Raemdonck, Esther Hauben, Raf Sciot, Paul Clement, Oliver Bechter, Benoit Beuselinck, et al.
Pages: 1 - 9 - Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors(2019)
Authors: Hans Wildiers, Annelies Verbiest, Herlinde Dumez, Evelyne Lerut, Steven Pans, Maarten Albersen, Benoit Beuselinck
Pages: 414 - 423 - Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma(2019)
Authors: Herlinde Dumez
Pages: 368 - + - Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy(2019)
Authors: Uros Milenkovic, Murat Akand, Lisa Moris, Tim Muilwijk, Youri Bekhuis, Annouschka Laenen, Ben Van Cleynenbreugel, Wouter Everaerts, Hendrik Van Poppel, Herlinde Dumez, et al.
Pages: 1857 - 1866 - Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies(2019)
Authors: Annelies Verbiest, Kevin Punie, Oliver Bechter, Hans Wildiers, Evelyne Lerut, Herlinde Dumez, Brigitte Decallonne, Paul Clement, Dirk Vanderschueren, Maarten Albersen, et al.
Pages: 169 - 179 - Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib(2019)
Authors: Maxime Vanmechelen, Diether Lambrechts, Annelies Verbiest, Patrick Schöffski, Herlinde Dumez, Evelyne Lerut, Maarten Albersen, Benoit Beuselinck
Pages: E235 - E246